Concepedia

Prevalence and risk factors of anti-tuberculosis drug-induced hepatitis in Malaysia.

OA Marzuki, A R M Fauzi, Shymaa E. Ayoub, Kamarul Imran Musa

PubMed · 2008 · 51 citations · 15 references

Abstract

The prevalence of hepatitis was 9.7 percent. The presence of HIV infection and extrapulmonary TB were significant risk factors for the development of hepatitis.

References

15

Evaluation of Clinical and Immunogenetic Risk Factors for the Development of Hepatotoxicity during Antituberculosis Treatment

Surendra K. Sharma, Arumugam Balamurugan, Pradip Kumar Saha et al. · American Journal of Respiratory and Critical Care Medicine · 2002 · 333 citations

, , +22

USPHS Tuberculosis Short-Course Chemotherapy Trial 21: Effectiveness, Toxicity, and Acceptability

Debra L. Combs · Annals of Internal Medicine · 1990 · 317 citations

Antituberculosis Drug–induced Hepatotoxicity

Jaime Ungo, Denis Jones, David Ashkin et al. · American Journal of Respiratory and Critical Care Medicine · 1998 · 288 citations

, , +21

Risk factors for hepatotoxicity from antituberculosis drugs: a case-control study.

J N Pande, Sarman Singh, GC Khilnani et al. · Thorax · 1996 · 243 citations · Full text

The natural history of histologically proved drug induced liver disease

Guruprasad P. Aithal, Christopher P. Day · Gut · 1999 · 202 citations · Full text